Abstracts Submission

TOP > Abstracts Submission
JSCO 2018 welcomes your abstract submission for presentations at the Annual Meeting in October 18-20, 2018. 

 

Submission Period

Abstract Submission for General Speakers:
  Thank you for your submission. Abstracts submission system is now closed.


 

Abstract Submission for Invited Speakers:
  It will be announced by email separately.

 

Submission Requirements

  1. The abstract submission is limited to JSCO members only. However, if you fulfill one of the conditions below, you will be qualified to submit the abstract as non-members:
    • an invited speaker to the Congress
    • include more than one JSCO members as coauthors in your abstract
    • belong to an overseas organization
  2. The head author, who is also a presenting author, is asked to make abstract submission.

 

※Admission to Japan Society of Clinical Oncology (JSCO)

   If you wish to become a member of JSCO, please visit the JSCO website for further details.

Contact: Secretariat of the Japan Society of Clinical Oncology
TEL:+81-75-751-7150 FAX:+81-75-761-9724
E-mail:office@jsco.or.jp

 

Submission Method

All abstracts should be submitted through the online abstract submission system. We suggest you to have enough time for abstract submission since the line may get busy for few days before the submission deadline.

 

※About Abstract Submission System
JSCO has introduced an abstract submission system for both general and invited speakers starting from JSCO 2014 Congress. This system enables JSCO members to obtain their registered membership data from "my ganchi" system and reduce the time to input their personal information when registering abstracts.
JSCO members are requested to confirm and update their registered membership data as necessary.

 

Submission Process

 1. JSCO Members and Applicants 

■General and Invited Speakers

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system. 
Step 2 Please enter your 5 digits Membership No., Login ID, and Password which are used when logging-in to "my ganchi" system. Then, click "Sign in" button.
※For applicants, please enter your tentative ID (TMP + 5 digits number) as Membership No. 
Step 3 Please check your information in "Your Profile" and "Head Author's Information" sections, and then start your abstracts submission. 
Step 4 Once the abstract registration completes, a confirmation email will be sent to your registered email address.
If you do not receive a confirmation email in 30minutes, please contact the Management Secretariat at jsco2018-abs@congre.co.jp.

※If you have forgotten your Login ID and Password used for "my ganchi" system, please click here

 

 2. JSCO Non-Members 

■General Speakers

※In order to submit your abstracts, you need to include more than one JSCO members as coauthors in your abstracts or belong to an overseas organization.

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system. 
Step 2 Click the "Registration as the head author" in Non-Members category located at the bottom of Top page, and open the registration page. 
Step 3 Enter your personal information on "Create a New Account" page. 
Step 4 Once the personal information registration completes, the message for completion will be shown together with your 1)ID for Abstract Submission, 2)Log-in ID, 3)Password on the screen.
Also, a confirmation email titled "My Account / Confirmation" will be sent to your registered email address. If you do not receive a confirmation email, please contact the Management Secretariat at jsco2018-abs@congre.co.jp.
Step 5 By clicking the button of "to TOP Page" at the foot of Registration Completion Page (mentioned on STEP 4 above), or by entering newly issued IDs and Password from Top page, you can confirm your personal information or enter your abstracts. 
Step 6 Once the abstract registration completes, the message for completion will be shown together with your ①ID for Abstract Submission, ②Log-in ID, ③Password on the screen. Also, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email in 30minutes, please contact the Management Secretariat at jsco2018-abs@congre.co.jp.

 

※For security reasons, we are not able to answer any questions about your passwords.

 ■Invited Speakers

Step 1 Please access the URL indicated in the email sent from the Management Secretariat, and enter your Access ID, Login ID, and Password. Then, click "Sign in" button.
Step 2

Please check your information in "Your Profile" and "Head Author's Information" sections. Then, click "Biography" button to enter your biography, and click
"Abstract Submission for Invited Speakers" button for abstract submission.

Step 3 Once the abstract registration completes, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email in 30minutes, please contact the Management Secretariat at jsco2018-abs@congre.co.jp.

 

Presentation Style

  1. General Abstracts
    (Doctors - Abstract & Presentation Slides: English, Presentation Language: English or Japanese)
    (Non-doctors - Abstract & Presentation Slides & Presentation Language: English or Japanese)
     * All doctors are requested to submit the abstracts in English.
    • The presentation will be in the form of an oral or poster presentation, and it will be left to the Congress President and the Program Committee Members' discretion.
    (1) Oral Presentation
    • Please make a PC-based presentation.
    (2) Poster Presentation
    • Please make a paper-based poster presentation.
    • The poster will be displayed for only one day.
    • Since there is no e-Poster presentation nor browsing, a pre-submission of the poster data is not necessary.

 

Important Notes for Submission

  • Items marked with "* asterisk" are the required information. If you fail to complete those required information, you are not able to proceed for registration.
  • Please answer the questions in each page, including COI Disclosure, Personal Information, Agreement on Submission, and Copyright.
  • Limitation for Registration  

     

      Doctors Non-doctors
    Total number of Authors
    (first author and co-authors)
    Up to 15 authors Up to 15 authors
    Total number of Affiliations Up to 15 affiliations Up to 15 affiliations
    Total number of characters
    for Abstract Title
    English: Up to 200 characters or
    approx. 28 words (including spaces)

    Japanese: Up to 40 characters
    English: Up to 200 characters or
    approx. 28 words (including spaces)

    Japanese: Up to 40 characters
    Total number of characters
    for Abstract Body
    English: Up to 2,000 characters or
    approx. 290 words (including spaces)
    English: Up to 2,000 characters or
    approx. 290 words (including spaces)
         OR
    Japanese: Up to 1,000 characters
    Presentation Language English or Japanese English or Japanese

 

Disclosure of COI (Conflict of Interest)

Industry-academic collaborative clinical oncology research entails benefits to society (public interest) from the fruits of discharging academic and ethical responsibility, as well as money, status, rights, and other benefits (private interest) acquired attendant on industry-academic collaboration. When these two types of benefit are in conflict within an individual researcher, it is called a “conflict of interest.” The occurrence of conflict of interest is unavoidable in today’s complex social activities, and legal restrictions apply to certain activities.

From JSCO Annual Meeting in 2007,  Clinical Oncology Research Conflict of Interest Policy was established, and in order to secure the fairness of the presentations for clinical research at Annual Meetings, conflicts of interest that presenting authors are obligated to disclose the COI status from 2008. Moreover, the guideline enforced from April, 2013, which is called "Oncology Research Conflict of Interest Policy  "and it applies not only for clinical research, but also all medical studies including bioscience research, basic medical research, clinical trials.

Matters for which disclosure is required shall be matters that occur from two year before abstract submission to the time of presentation; it is provided. Please refer to the COI page on Online Abstract Submission system for details, and mark the boxes which match with your status. The amounts for which self-declaration is required are prescribed for each matter requiring disclosure as follows. Presenting authors who are officers or advisors of companies or for-profit organizations, or the profit from sales of stock, or patent royalties or licensing fees from companies are 1 million yen or more. Honoraria (such as lecture fees) or report manuscript fees paid by a company are 500,000 yen or more. Report research funding is 1,000,000 yen or more. For more details about COI, please refer to JSCO Website.

 

Please download the COI disclosure PDF sample.

COI Disclosure Sample Form
(Japanese version)

COI Disclosure Sample Form
(English version)

 

Categories

(1)Speciality

01 Internal medicine 06 Orthopedics 11 Pediatric 16 Clinical pathology
02 Surgery 07 Oral surgery 12 Anesthesiology 17 Neuropsychiatry
03 Obstetrics & Gynecology 08 Ophthalmology 13 Neurosurgery 18 Palliative medicine
04 Radiology 09 Otolaryngology 14 Plastic surgery 19 Pharmacology
05 Urology 10 Dermatology 15 Basic medicine 20 Nursing

 

(2)Areas of Research : Classified by Organ, etc.

01 Pediatrics 09 Small / Large Intestine 17 Kidney /Urinary Tract / Bladder
02 Neurologic 10 GIST (Gastrointestinal Stromal Tumor) 18 Prostate / Male Genital
03 Eyes 11 Liver 19 Endocrine
04 Oral Cavity 12 Gallbladder / Biliary Tract 20 Skin
05 Head and Neck 13 Pancreas 21 Bone and Soft Tissue
06 Breast 14 Lung / Mediastinum/Pleura 22 Hematopoietic Organs / Lymphatic System
07 Esophagus 15 Uterus 23 NET (Neuroendocrine Tumor)
08 Stomach / Duodenum 16 Ovary 24 Others

 

(3)Technique

01 Epidemiology and Prevention 13 Endoscopic Treatment 25 Intensive Treatment
02 Pathology 14 Surgical Techniques 26 Supportive Therapy
03 Basic Oncology 15 Endoscopic Surgery 27 Palliative Therapy
04 Genomic Gene 16 Chemical Treatment 28 QOL
05 Tumor Immunity 17 Targeted Therapy 29 Team Medical Care
06 Diagnosis 18 Endocrine Hormone Therapy 30 Cancer Nursing
07 Genetic Diagnosis 19 Immunotherapy 31 Rehabilitation
08 Imaging 20 Transplantation and Cellular Therapy 32 Patient Support
09 Sensitivity Test 21 Gene Therapy 33 Regional Collaboration
10 Biomarkers 22 Radiation Therapy 34 Health Economics
11 Translational Research 23 IVR (Interventional radiology) 35 Health Policy
12 Clinical Trial 24 Topical Therapy 36 Medical Equipment and Medical Engineering

 

Excellent Abstracts & Best Abstracts Awards

The Congress President and the Program Committee will select excellent abstracts from the submitted general abstracts. The best abstracts will then be chosen from those selected abstracts. The head authors of the best abstracts are requested to make an oral presentation at the Plenary Session either in English or Japanese.

 

  • The Congress President and the Program Committee will select excellent abstracts by thoroughly reviewing the submitted general abstracts.
  • The head authors whose abstracts have been selected as excellent abstracts are required to submit the abstract in English, in case if the submitted abstracts were in Japanese.
  • The excellent abstracts will be posted on the JSCO website.
    On the page for public: Authors' name, affiliation and abstract
    On the page for JSCO members: Authors' name, affiliation, abstract and presentation slides

 

Result of Abstract Acceptance & Program Allocation

The presentation style will be decided by the Congress President and the Program Committee Members. Please kindly note that we sometimes may not be able to meet your preference.

 

Notification for Acceptance/Rejection of Abstracts, Presentation Style & Date/Time

The notification of the abstracts result, presentation style, date and time will be sent to the head authors' registered email address from the Management Secretariat (jsco2018-abs@congre.co.jp) at the end of July.

 

Copyright of Accepted Abstracts

The copyright of all accepted abstracts will be transferred to JSCO.
The abstracts submitted by the invited speakers will be posted on the JSCO website.

 

Online Abstract Submission System

Click the button below to start your abstract submission. Please note in advance that you are not able to save the data in middle of the submission procedure.

Online Abstract Submission System

Inquiries for Abstract Submission

 

c/o Congress Corporation
5-1 Kojimachi, Chiyoda-ku, Tokyo 102-8481, Japan
TEL: +81-3-5216-5318
FAX: +81-3-5216-5552
E-mail : jsco2018-abs@congre.co.jp